Don’t mandate country of origin labelling: ASMI


lots of colourful different medicines
ASMI has said country of origin statements, graphics and visual representations should not be mandatory for therapeutic goods labels, in its submission to the Government’s review of country of origin labelling. “ASMI supports sponsors who wish to include a country of origin statement on therapeutic goods labels," Steve Scarff, ASMI regulatory and scientific affairs director

This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Macular oedema treatment to be available on PBS
Next Cause marketing: the need beyond your pharmacy catchment